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ENGLISH SUMMARY 
Edentulism can lead to functional and cosmetic problems. Placement of implants is a 
well-documented treatment to replace missing teeth. Occasionally, long-term 
edentulism, tooth extractions, or infections can lead to severe atrophy of the alveolar 
crest. If implants are placed in an inadequate bone volume, it can lead to adverse 
angulations, mechanical overload, and esthetic dissatisfaction. Alveolar ridge 
augmentation with autogenous bone grafts from the mandibular ramus or the iliac 
crest has been the preferred treatment for the reconstruction of horizontal alveolar 
defects. This procedure demands a second surgical site, risk of donor site morbidity, 
postoperative complications, and increased costs. To simplify the surgical procedure, 
to reduce the risk of complications, and to reduce the cost, the use of bone substitutes 
has increased. Due to the lack of osteoinductive potential of bone substitutes, different 
ratios of particulate autogenous bone (PAB) have been added to the graft. 
However, the optimal ratio of a bone substitute and PAB and its effect on the 
consolidation period is currently unknown. To avoid inappropriate tissue reactions 
and to be able to choose the right composition of the graft material as well as the 
optimal consolidation period to optimize the result, knowledge about the regeneration 
potential of the graft materials is essential. The present Ph.D. thesis aimed to evaluate 
the importance of adding different ratios of PAB to a DBBM and compare it to ABB 
from the mandible covered with DBBM according to the principles of GBR, using a 
resorbable collagen membrane. The thesis comprises a systematic review (I), a 
laboratory study (II), and two preclinical studies in minipigs (IV, V). Study I evaluated 
previous studies on LRA with DBBM alone or in combination with PAB to investigate 
the extent of previous research on this topic. In study II, different compositions of 
DBBM and PAB were evaluated in a laboratory to simulate the situation before the 
graft was placed in the patients.  In study III and IV, lateral GBR augmentation was 
performed in the mandible of minipigs with three different particulate compositions 
of DBBM and PAB and with ABB covered by DBBM. The animals were euthanized 
after 10, 20, and 30 weeks, respectively, to assess the outcome after three different 
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healing periods. The histologic, histomorphometric, and radiographic outcomes were 
evaluated. 
No differences could be detected between the graft materials regarding the 
formation of bone over time. ABB covered by DBBM maintained the width of the 
graft material better compared to particulate grafts, but no difference regarding the 
width gain could be detected among the particulate grafts.  
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DANSK RESUME 
Manglende tænder medfører ofte funktionelle og kosmetiske gener og tandimplantater 
anses for en veldokumenteret behandlingsmetode til erstatning af manglende tænder.  
Imidlertid kan indsættelse af tandimplantater i den funktionelle og kosmetiske 
korrekte position være vanskelig eller umulig som følge af manglende kæbeknogle.  
Transplantat med knogle fra en anden del af patientens underkæbe eller fra 
hoftekammen, har i mange år været den mest almindelige metode for at genopbygge 
manglende kæbeknogle. Anvendelse af patientens egen knogle fra underkæben eller 
hoftekammen er imidlertid forbundet med risiko for komplikationer svarende til 
donorstedet, hospitalisering og øgede behandlingsudgifter.  
For at simplificere det kirurgiske indgreb, minimere generne for patienter og for 
at undgå hospitalisering, benytter man sig i stigende grad af 
knogleerstatningsmaterialer alene eller i kombination med en reduceret mængde 
knogle fra patienten. Det ville være en fordel hvis patientens egen knogle helt eller 
delvist kunne erstattes af et knogleerstatningsmateriale.  
Det optimale blandingsforhold af knogleerstatningsmateriale og patientens egen 
knogle i henhold til at generere mest knogle samt den optimale helingsperiode er 
endnu ukendt. Nærværende ph.d.-afhandling har til formål at undersøge forskellige 
blandingsforhold af knogleerstatningsmateriale fra kvæg og patientens egen knogle i 
forbindelse med opbygning af kæbeknoglen.     
Nærværende ph.d.-afhandling inkluderer en systematisk oversigtsartikel (I), en 
laboratorieundersøgelse (II) samt to dyreksperimentelle undersøgelser (III, IV).  
Den systematiske oversigtsartikel (Studie I) opsummerede den eksisterende viden om 
anvendelsen af knogleerstatningsmateriale fra kvæg i kombination med patientens 
egen knogle ved genopbygning af kæbeknoglen. Laboratorieundersøgelsen (Studie II) 
evaluerede forskellige blandingsforhold af knogleerstatningsmateriale og knogle med 
det formål at etablere et sammenligningsgrundlag for vurdering af de forskellige 
blandingsforhold. De dyreeksperimentelle forsøg (studie III og IV) evaluerede 
forskellige blandingsforhold af knogleerstatningsmateriale fra kvæg og egen knogle 
ved opbygning af kæbeknoglen med det formål at estimere mængden af knogle samt 
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volumenstabiliteten af transplantationsmaterialet ved forskellige helingsperioder.  
 Resultaterne viste at der ikke var en forskel på mængden knogle efter 
genopbygning med knogleerstatningsmateriale alene sammenlignet med når man 
tilføjede forskellige mængde af patientens egen knogle. Bredden af knoglen bevaredes 
bedre med en knogleblok fra underkæben sammenlignet med forskellige blandinger 
af knogleerstatningsmateriale og forskellige mængde   af patientens egen knogle. 
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BACKGROUND 
Dental implants have been used increasingly during the last 40 years with high 
survival rates of suprastructures and implants (1-4). Adequate height and width of the 
alveolar process are the main requirements for optimal osseointegration of implants 
(1,5,6). However, tooth extraction, infection, or long-term edentulism may lead to 
severe atrophy of the alveolar crest and loss of the buccal bone (7-9). Placement of 
dental implants in inadequate bone volume may lead to adverse angulations, 
mechanical overload, and esthetic dissatisfaction. Therefore, bone augmentation 
before implant placement is often necessary when the dimension of the alveolar 
process is insufficient (1,5,6). Different procedures for bone augmentation have been 
described to enhance the width of the alveolar process (10-13).  
ABB covered by a non-resorbable bone substitute and a resorbable collagen 
membrane is a commonly used surgical procedure to enhance the width of the alveolar 
process since it possesses osteoinductive and osteoconductive properties (14-18). 
However, the harvesting of an ABB from the mandible or the iliac crest is associated 
with the risk of morbidity at the donor site, increased costs, prolonged treatment time, 
hospitalization and occasionally the need for general anesthesia, and unpredictable 
resorption of the graft material (19-21). Hence, bone substitutes alone or in 
combination with PAB are used increasingly to simplify the surgical procedure. It has 
been suggested that the ideal bone substitute should be biocompatible, resorbable, and 
replaced with new bone, and possess properties that increase the incorporation of the 
graft (22, 23).  
One of the most documented bone substitutes for intraoral augmentation is Bio-
Oss (Geistlich Pharma, Wolhusen, Switzerland), a DBBM with excellent 
osteoconductive properties. To add osteoinductive properties to the graft material, 
different ratios of PAB have been added to DBBM and assessed for LRA, vertical 
augmentation, and maxillary sinus floor augmentation (24-37). It has been proposed 
that the ratio of DBBM and PAB could influence the pattern of bone remodeling (38) 
and that DBBM may delay bone formation in the early healing phase (39-42). 
However, a RCT, evaluating bone formation histologically and scintigraphically after 
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sinus floor augmentation, demonstrated no difference in bone formation between 
100% DBBM and a mixture of DBBM and PAB (43). 
Inconsistent conclusions regarding the composition of DBBM and PAB have also 
been presented on dimensional stability of different graft compositions. A newly 
published RCT demonstrated no significant difference in width changes after lateral 
GBR augmentation with DBBM alone compared with ABB covered by DBBM and a 
collagen membrane after 18 months (32). However, a previous systematic review 
concluded that ABB maintained the width better compared with particulate grafts 
(44), which has been confirmed in a later systematic review that also concluded that 
DBBM alone revealed reduced resorption of the augmented region compared with 
different ratios of DBBM and PAB (12). From a patient perspective, it would be an 
advantage if the need for the harvesting of AB could be reduced and partly or 
completely replaced by a bone substitute. This could minimize donor site morbidity, 
patient discomfort and treatment time. However, this requires a greater understanding 
and knowledge about the regenerative outcome with different compositions of DBBM 
and PAB and the effect on the consolidation period after lateral GBR augmentation. 
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INTRODUCTION 
BONE 
The main supportive organ in the human body is the skeleton, in which bone tissue 
constitutes the major part. Bone is a complex, cellular, vascularized, and highly 
mineralized connective tissue. The major functions of bones are to provide 
mechanical support and a framework for the body, to protect vital organs, to provide 
an environment for hematopoiesis in the bone marrow, and to act as a metabolic 
reservoir for minerals, in particular calcium (45, 46). 
The bones in the human body can be categorized as long bones, short bones, 
irregular bones, and flat bones. Morphologically, bones are divided into cortical 
(80%) and trabecular bone (20%). Cortical bone is compact or dense and forms the 
hard, outer layer of bones, while trabecular bones have a spongy structure, forms the 
inner layer of the bone, and ensures the stability and elasticity of the skeleton (47, 48). 
The outer layer of the cortical bone is called the periosteum, and it consists of an outer 
and an inner fibrous layer with osteogenic potential. The inner surface of the cortical 
bone and the surfaces of the trabecular bone has a layer called endosteum. 
Microscopically, mineralized bone appears in two forms: woven and lamellar. Woven 
bone appears during early bone formation (i.e. during growth and healing). Lamellar 
bone is a mature bone and is formed during modeling and remodeling. 
Bone is primarily composed of mineral, mainly hydroxyapatite, 
Ca10(PO4)6(OH)2 (70%). The bone matrix mainly consists of type I collagen but also 
proteins such as osteocalcin, bone sialoprotein, osteopontin, osteonectin, and growth 
factors (e.g. bone morphogenic proteins (BMPs)). The remaining content is water and 
lipids (49). 
 
BONE CELLS 
Four different cell types are found in bone: osteoblasts, bone lining cells, osteocytes, 
and osteoclasts. The osteoblasts, bone lining cells, and osteocytes derive from 
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mesenchymal stem cells, while the osteoclasts are formed by giant multinucleated 
cells (49). 
 
Osteoblasts 
Bone formation is the main function of the osteoblast, and they represent 4-6% of the 
bone cells. Osteoblasts derive from mesenchymal stem cells, which can differentiate 
into fibroblasts, chondrocytes, myoblasts, and adipocytes (50). 
Four stages of maturation have been identified in the differentiation of an 
osteoblast: the preosteoblasts, osteoblast, osteocyte, and bone-lining cell.  If the 
appropriate stimuli are present, the mesenchymal stem cells form preosteoblasts, 
which resemble osteoblasts but cannot produce mineralized tissue. They activate 
mature osteoblasts that secrete the organic component of bone, predominantly type I 
collagen, which is essential for later mineralization of hydroxyapatite. The collagen 
excreted from the osteoblasts forms osteoid and later mineralized bone tissue. 
During bone formation, osteoblasts can be trapped within the secreted matrix and 
differentiate into osteocytes. Some osteoblasts remain on the surface of the new bone 
and differentiate into inactive bone-lining cells, and the majority 
undergo apoptosis and degenerate (50-70%) (51). Osteoblasts also produce factors 
like microphage colony stimulating factor, osteoprotegerin, and RANKL to regulate 
the differentiation of the bone-resorbing osteoclasts. These factors play an important 
role in osteoclast formation, activation, and resorption (51). 
 
Osteocytes 
Osteocytes are terminally differentiated osteoblasts that are embedded in the matrix 
of newly formed bone (52), and several theories have been proposed to explain the 
transformation of osteoblasts into osteocytes (53). The osteocytes represent 95% of 
all bone cells and are considered to play an important role in bone formation and bone 
remodeling (54). 
Osteocytes lie within lacunae in the newly formed bone matrix where they can 
exist for a long time but eventually undergo apoptosis. In the lacunae, they are isolated 
and spatially separated from each other. However, they are still interconnected with 
 17 
each other and with bone-lining cells as well as osteoblasts on the bone surface via 
extended projections through channels in the bone matrix called canaliculi (51, 52, 
55, 56), in which they can detect mechanical load through a fluid (57, 58), and if 
microdamage occurs, this function can induce bone repair. Osteocytes can regulate 
skeletal homeostasis by regulating secretion and expression of insulin-like growth 
factor, osteocalcin, and sclerostin. They also provide the majority of RANKL that 
regulates osteoclast formation in cancellous bone (59, 60). 
 
Bone lining cells 
The bone lining cells mainly derive from osteoblast and are flattened, thin 
differentiated cells located on a thin layer of unmineralized collagen matrix covering 
the bone surface (61) and take part in the homeostasis of minerals and can be activated 
and differentiated into osteogenic cells (61). If exposed to parathyroid hormone 
(PTH), bone lining cells secrete collagenase to remove the collagen matrix to make 
osteoclasts attach to bone (62). 
 
Osteoclasts 
Osteoclasts derive from hematopoietic stem cells and share precursors with 
macrophages and monocytes. Osteoclasts are large multinucleated cells formed by the 
fusion of mononuclear progenitors (63) and the only cell type that can resorb bone. 
Osteoclast formation, activation, and resorption are regulated by the ratio of RANKL 
(which binds to RANK and activates osteoclastogenesis) to osteoprotegerin (which 
inhibits osteoclastogenesis), Interleukin-1 and Interleukin-6, microphage colony 
stimulating factor, PTH, 1,25-dihydroxyvitamin D and calcitonin (64). 
Resorbing osteoclasts secrete hydrogen ions through proton pumps and chloride 
channels and generates an acidic environment in the resorption lacunae, and when the 
pH is decreased to 4.5 within the bone-resorbing space, the hydroxyapatite is 
dissolved. This is followed by secretion of tartrate-resistant acid phosphatase, 
cathepsin K, matrix metalloproteinases, and gelatinases from cytoplasmic lysosomes 
to digest the organic matrix. The result of this process is the formation of Howship’s 
lacunae on the surface of trabecular bone and Haversian canals in cortical bone. The 
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resorption phase is completed by mononuclear cells when osteoclasts undergo 
apoptosis. After the resorption phase, the osteoblasts are activated and started to form 
osteoid to fill the cavities (65). Hence, osteoclast also regulates osteoblast function 
(47). 
 
BONE FORMATION AND REMODELING 
Bone is a dynamic organ that constantly changes. Two types of bone formation have 
been described: endochondral ossification and intramembranous ossification (47, 49). 
The long bones, pelvis, skull base, and vertebral column are formed by endochondral 
ossification, which is the most common mechanism of primary bone function. 
Endochondral ossification involves the differentiation of mesenchymal cells into 
chondrocytes, which produce a framework of hyaline cartilage. Maturation of the 
cartilage occurs through hypertrophy of chondrocytes, which is followed by erosion 
of the matrix. The chondrocytes degenerate and die, and the remaining cartilage 
mineralizes. Mesenchymal cells infiltrate the calcified cartilage template by invading 
blood vessels and may be differentiated into osteoblasts and subsequently start bone 
formation (66). 
The mandible, the flat bones of the skull, and the clavicle are formed by 
intramembranous ossification where mesenchymal cells differentiate directly into 
osteoblasts that deposit organic matrix composed of type I collagen in a trabecular 
pattern. Calcium phosphate in the form of hydroxyapatite crystals is subsequently 
deposited in the matrix to form bone (47, 49). 
Bone remodeling occurs through the functional unit of cells called the basic 
multicellular unit. It consists of osteoclasts resorbing the bone, osteoblasts replacing 
the bone, the osteocytes within the bone matrix, the bone-lining cells covering the 
bone surface, and the capillary blood supply (51). 
Bone remodeling starts with an initiation phase, including recruitment of 
osteoclast precursors, differentiation into mature osteoclasts, and activation and 
maintenance of bone resorption. Then, a reversal period will follow where osteoclast 
activity is converted to osteoblast activity. During the reversal period, osteoclastic 
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bone formation is inhibited, the osteoclasts undergo apoptosis, and the osteoblasts are 
recruited and start to differentiate. The final stage is called the termination phase, 
where the bone is formed by the osteoblasts (67). The resorption process lasts for three 
to four weeks, and the duration to complete the subsequent bone formation is three to 
four months. The bone remodeling process is shorter in cortical bone compared to 
cancellous bone, where the process lasts for about 200 days (51). 
 
GRAFT MATERIALS 
AUTOGENOUS BONE 
AB originates from the same individual receiving the graft and has been described as 
the preferred bone grafting material due to its osteoconductive, osteoinductive, and 
osteogenic properties (68). The most common donor sites for pre-implant 
reconstruction of the alveolar crest are the mandibular retromolar area, the chin, and 
the iliac crest (14, 15, 69, 70). Autogenous grafts from the mandible or the iliac crest 
can be used as a block graft or in particulate form. The use of block grafts is most 
common for the LRA procedure when treating larger defects or edentulous areas, but 
particulate grafts have been evaluated as well (71, 72). 
Some essential requirements have been described for the successful incorporation of 
the AB graft (73). 
 
I) Embryonic origin: Membranous bone seems superior over enchondral 
bone, probably due to the biological difference that leads to an alteration 
in revascularization. 
II) Revascularization: Incorporation, remodeling, and maintenance of the 
AB graft are related to the revascularization rate. 
III) Graft structure: Revascularization differs between cortical and 
cancellous bone grafts, where the cortical bone is densely packed and 
cancellous bone is porous with marrow tissue between the trabeculae 
and the vascular ingrowth occurs more rapidly. 
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IV) Stability of the graft: A rigid fixation will improve graft integration and 
decrease the rate of resorption. 
 
DEPROTEINIZED BOVINE BONE MINERAL 
DBBM belongs to the group of xenogeneic bone grafts, which means it originates 
from another species than the host and is a natural bone mineral characterized by its 
high structural and chemical similarity to the bone. The organic portion of the material 
is removed to avoid disease transmission. The most documented DBBM used for 
augmentation procedures before implant placement is Bio-Oss (Geistlich Pharma, 
Wolhusen, Switzerland). It has been documented in several preclinical and clinical 
studies and is frequently used for different bone augmentation procedures. 
The inorganic bone matrix of Bio-Oss seems to have a microporous structure 
comparable to the human cancellous bone and several studies have documented that 
Bio-Oss possesses important properties like biocompatibility and osteoconductivity 
when used as a grafting material (22, 24, 25, 27, 31-33, 36, 37, 74-82). 
In the literature, there is controversy about whether DBBM is a resorbable 
material. Some authors have claimed that DBBM probably is a non-resorbable 
material or not (26, 83-85). Several authors have claimed the opposite due to 
observations of a decreased area fraction of DBBM over time and signs of resorption 
(i.e. resorption lacunas and the presence of osteoclasts on the particle surface) (74, 86-
94). However, histomorphometrical analyses of biopsies harvested 11 years after 
maxillary sinus floor augmentation with Bio-Oss and PAB demonstrated Bio-Oss 
particles well integrated into lamellar bone with no significant changes in particle size, 
indicating that Bio-Oss is a stable non-resorbable bone substitute (95). 
Since the organic part in DBBM has been extracted, the material would not possess 
any osteoinductive properties, and the integration of the graft material to the bone is 
claimed to be achieved only by osteoconduction (96). To enhance graft integration by 
osteoinduction, different ratios of PAB have been added to the graft in augmenting 
procedures of the alveolar ridge and the maxillary sinus. However, the optimal 
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composition of DBBM and PAB and its effect on the consolidation period is still 
unknown for lateral augmentation. 
 
RESORBABLE COLLAGEN MEMBRANES 
Almost three decades ago, the original hypothesis of GBR was presented (97). It 
suggested that placement of a resorbable or non‐resorbable barrier could exclude 
certain types of cells, such as connective tissue and rapidly proliferating epithelium, 
to improve the growth of slower‐growing cells capable of forming bone. Hence, by 
preventing the access of non‐osteogenic tissues, mesenchymal stem cells would be 
solely allowed to repopulate the bone defect (97-99). It has also been proposed that 
resorbable, naturally derived collagen membranes promote the upregulation of genes 
related to bone formation and bone remodeling in the underlying defect compared to 
the expression of these genes in untreated sham defects in the rat femur. Additionally, 
the presence of the non-resorbable collagen membrane over the defect seemed to 
improve the expression of the pro‐inflammatory cytokine TNF-α  (100), which is 
essential for intra‐membranous bone formation (101). 
Bio-Gide (Geistlich Pharma, Wolhusen, Switzerland) is a well-documented, 
double-layered, non-cross-linked, resorbable collagen membrane of porcine origin. 
The Bio-Gide membrane has been used for different bone augmentation procedures, 
including LRA, maxillary sinus floor augmentation, ridge preservation, and guided 
periodontal regeneration, demonstrating decent biocompatibility and an enhanced 
formation of bone (17, 18, 24, 31-33, 36, 37, 77). The membrane has been proposed 
to resorb within eight weeks without inflammation (102, 103). As the Bio-Gide 
membrane is made of collagen, allergic reactions and inflammatory tissue reactions 
cannot be excluded, though this is extremely rare (103). 
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GRAFT HEALING 
Osteogenesis, osteoinduction, and osteoconduction are the three essential elements of 
bone regeneration along with osteointegration, which is the final bonding between the 
host bone and the graft material (104). 
 
Osteoconduction 
The process in which biological or non-biological materials serve as a scaffold allows 
a three-dimensional ingrowth of capillaries, perivascular tissues, and mesenchymal 
stem cells from the recipient bed into the graft (68, 105, 106). This scaffold permits 
the formation of new bone determined by the biology of the graft and the mechanical 
environment of the host-graft interference (107). 
 
Osteoinduction 
The process where a material is capable of releasing factors from the graft matrix to 
stimulate cells from the host to form new bone (68). A potent inductor in osteogenic 
activities during bone repair is BMPs. They can regulate the production and activity 
of growth factors that are essential for bone formation (108). The three phases during 
osteoinduction are chemotaxis, mitosis, and differentiation. 
Chemotaxis- In response to a chemical gradient (e.g. BMP), factors inducing bone 
formation direct the migration of cells to the area in which they are to be utilized. 
Mitosis- Stimulation of mitogenic and proliferative activity in these cells. 
Differentiation- The cells differentiate into chondroblasts and form cartilage, which 
becomes revascularized by invading blood vessels. After mineralization of the 
cartilage, osteoblasts are differentiated to form new bone (109). 
 
Osteogenesis 
Osteogenesis is the ability of the graft to produce new bone. This process depends on 
the presence of living bone cells in the graft. A graft material with osteogenic 
properties contains cells with the potential to form bone or the ability to differentiate 
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into bone-forming cells. These cells participate in the process where the graft is 
incorporated with the host bone. The role of osteogenesis as a mechanism during graft 
healing of non-vascularized grafts has been advocated to be of less importance 
compared to the mechanism of osteoconduction (68). 
 
HEALING OF DEPROTEINIZED BOVINE BONE MINERAL 
A previous experimental study in dogs described different phases during the 
incorporation of DBBM collagen in the host tissue (110). In the primary phase, the 
biomaterial was trapped in the fibrin network of the coagulum, and the polymorphous 
nuclear (PMN) cells migrated to the surface of the DBBM particles. In the second 
phase, PMN cells were replaced by osteoclast. The osteoclasts lived through 
osteopontin-positive cement lines on the surface of the particles, indicating that the 
cells were properly attached and removed material from the surface of the DBBM 
particles. After 7-14 days, the osteoclasts disappeared and were followed by 
osteoblasts, producing bone mineral in the provisional matrix. In the third phase, 
DBBM particles became integrated into the bone. 
A previous experimental study in minipigs assessing the healing of DBBM 
compared to AB presented a delayed formation of bone in the DBBM group compared 
to the bone after eight weeks. However, the total fraction of mineralized tissue 
(DBBM particles + bone) was superior for the DBBM graft (41). It has previously 
been proposed that it seems likely that this mineralized tissue of bone and DBBM 
particles provides biological support to implants placed in the graft comparable or 
even exceeds that of bone (75). 
 
HEALING OF AUTOGENOUS BONE 
Several factors influence the integration of ABB, and the most important are the 
stability of graft, the vascularity of the recipient site, and the quantity of cellular 
marrow in the graft (111). 
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During healing of AB graft, most of the graft undergoes necrosis. However, cells of 
the bone marrow, periosteum, endosteum, and bone surface may survive (112). 
Clinically, the faith of non-infected bone graft can be either incorporation in the 
surrounding bone, where the biological, mechanical, and esthetical characteristics will 
be shared between the graft and the host bone over time, or sequestration, where a 
foreign body reaction will occur and the bone will be encapsulated in fibrous tissue 
(106). 
Histologically, three phases appear during incorporation: inflammation, 
consolidation, and remodeling (113). 
 
I) Inflammation- A hematoma surrounds the graft, and platelets are 
attracted by a fibrin clot. The graft is invaded by leucocytes and 
macrophages. 
II) Consolidation- Differentiation of osteoclasts that starts to resorb the 
graft. Recruitment of mesenchymal cells as a response to growth factors 
and BMPs (osteoinduction). The mesenchymal cells differentiate into 
osteoblasts that deposit osteoid on the trabeculae of the graft, which 
serves as a scaffold for the osteoblasts (osteoconduction). 
III) Remodeling- The remodeling process for AB continuous for a week to 
years and the graft is contentiously replaced by substitution. 
 
Bone blocks from the mandibular ramus undergo reverse creeping substitution, which 
means it takes longer for the graft to resorb compared to the creeping substitution of 
cancellous grafts. Hence, it can maintain the osteoconductive purpose for a longer 
period (68). 
The preparation of the recipient bed might be an important factor for incorporation 
and volume resistance to the graft since it gives access to cells from the host bone and 
local blood supply (114-116). 
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LATERAL AUGMENTATION 
When the width of the alveolar process at the recipient site presents an insufficient 
dimension for implant placement, LRA procedures are required. To enhance the width 
of the alveolar process, several surgical procedures have been used, including GBR, 
alone or in combination with graft materials, block grafts, split-ridge osteotomy, and 
osteodistraction. A previous study could not present an advantage to use one 
augmentation technique over another (10). 
When treating larger edentulous defects, ABB has previously been recommended 
(117). However, due to the risk of donor site morbidity, and a prolonged treatment 
time, the choice of surgical method must be considered individually. When using 
particulate grafts with DBBM, the GBR technique with a resorbable membrane has 
been used widely with satisfactory results (24, 31-33, 36, 37, 77). One common 
complication in GBR is soft tissue dehiscence and exposure of the membrane, which 
might lead to a bacterial infection and compromised graft healing. However, this is a 
more common complication in non-resorbable membrane sites. 
The optimal ratio of DBBM and PAB is still unknown, as well as the optimal 
consolidation period. To the best of the authors’ knowledge, different ratios of DBBM 
and PAB have never been compared to ABB covered by DBBM at different time 
points after lateral GBR augmentation. 
 
THE EXPERIMENTAL MODEL 
Animal studies are useful to study and compare the biological behavior of bone 
grafting materials. Minipigs are generally attractive for bone research due to their 
similarity to humans in terms of anatomy, bone mineral density, bone remodeling rate, 
and healing potential (118). They have an advantage from domestic pigs, which have 
been proven to be difficult to handle due to their size and aggressive temper (119, 
120). Additionally, minipigs have a reduced linear growth pattern compared to 
domestic pigs, and they reach skeletal maturity earlier (119). 
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HISTOMORPHOMETRY 
Bone histomorphometry is a quantitative histological examination of an undecalcified 
bone biopsy that is conducted to acquire quantitative information on bone remodeling 
and bone structure (121). This method is a well-documented research tool to evaluate 
the healing process of different bone substitutes (122). In histomorphometry, bone has 
three definitions (123). 
I) Mineralized bone matrix excluding osteoid; this is bone as a hard tissue. 
Osteoid, also called pre-bone, is a bone matrix that is not yet 
mineralized. 
II) Bone matrix, which includes both mineralized bone and osteoid. 
III) Tissue that includes bone marrow and other soft tissues as well as bone 
matrix. 
Histological sections are two-dimensional, but they represent a three-dimensional 
structure. It is possible to measure their area, length, number, and the distance between 
points or lines. While bone histomorphometry allows us to understand this three-
dimensional structure, it has technical limitations, protocol complexities, and financial 
and time costs. Cutting and grinding bone blocks may also damage the interface and 
could mar the results (124). 
Histomorphometric results should be presented strictly and consistently in two 
dimensions using the term bone area or the corresponding three-dimensional results 
using the term bone volume (123). A mixture of the two terms should not be used 
within the same study, and they should be distinguished. 
In dentistry, histomorphometry is used to assess the bone formation and residual 
DBBM particles through a two-dimensional definition (25, 26, 28, 30, 34, 88, 91, 93, 
125). In study III, the histomorphometric results were presented strictly as two-
dimensional, and the definition of bone used is the second definition (i.e. bone matrix), 
which includes both mineralized bone and osteoid. However, when histologically 
assessing the width measurements of the graft, the first definition was applied (i.e. 
mineralized bone and osteoid were separated) to assess the level of mineralization of 
the graft. 
 27 
AIMS 
The overall aim of this thesis is to evaluate the histologic and radiographic outcomes 
of lateral GBR augmentation with different compositions of DBBM and PAB and 
ABB covered by DBBM and a resorbable collagen membrane. 
 
Specific aims 
 
1. To demonstrate a histomorphometric baseline for different compositions of 
DBBM and PAB. 
 
2. To histomorphometrically evaluate the regenerative outcome over time for 
different compositions of DBBM and PAB, used for lateral GBR 
augmentation. 
 
3. To histologically evaluate the ingrowth of bone into the graft over time for 
different compositions of DBBM and PAB used for lateral GBR 
augmentation. 
 
4. To radiographically evaluate the width changes over time for different 
compositions of DBBM and PAB and ABB covered by DBBM used for 
lateral GBR augmentation. 
 
5. To radiographically evaluate the volume changes over time for different 
compositions of DBBM and PAB and ABB covered by DBBM used for 
lateral GBR augmentation. 
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HYPOTHESES 
 
• There is a difference in the clinically estimated area fraction of bone, NMT, 
and DBBM before grafting with different ratios of DBBM and PAB 
compared to the histomorphometrically evaluated percentage of bone, NMT, 
and DBBM. 
 
• There are no histomorphometrical or histological differences between 
DBBM alone and different compositions of DBBM and PAB used for lateral 
GBR augmentation. 
 
• There are no differences in width or volumetric changes between different 
compositions of DBBM and PAB and ABB covered with DBBM and a 
resorbable collagen membrane used for lateral GBR augmentation. 
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MATERIALS AND METHODS 
EXPERIMENTAL OUTLINES 
Paper I 
Human studies assessing the outcome of lateral GBR augmentation with different 
ratios of DBBM and PAB were evaluated on the following parameters: 
 
Primary outcome measures 
• Survival of suprastructures 
• Survival of implants 
 
Secondary outcome measures 
• Bone regeneration 
• Gained width of the alveolar process 
• Width reduction of the graft material 
• Volumetric stability of the graft material 
• Patient-reported outcome measures 
• Complications related to the surgical procedure 
 
Search strategy: 
Medline (PubMed), Cochrane database, and Embase searches were conducted by 
including studies published in English from January 1, 1990 to May 1, 2016. The 
search strategy utilized a combination of controlled vocabulary (MeSH) and free-text 
terms. The search strategy is illustrated in Figure 1. 
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Figure 1. Search strategy in study I 
 
Inclusion criteria: 
• Human studies assessing lateral GBR augmentation with Bio-Oss alone or 
mixed with PAB 
• Delayed implant placement 
• A minimum of five patients 
Exclusion criteria: 
• Studies using Bio-Oss blocks alone or Bio-Oss blocks in combination with 
granules were excluded if the outcome measures could not be identified for 
granules alone 
• Studies using unknown ratios of Bio-Oss and PAB 
• Immediate implant placement 
 
Paper II 
This study was conducted to estimate the area fraction of different ratios of DBBM 
and PAB before grafting using an in vitro model. Different ratios of DBBM and PAB 
were evaluated histologically to estimate the area fraction of the different tissues in 
the graft material before it was placed in the patient to demonstrate a 
histomorphometric baseline. 
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Paper III and IV 
The study included 24 adult female Göttingen minipigs (Ellegaard Göttingen 
Minipigs A/S, Dalmose, Denmark) with a mean age of 18 months (range: 17-19 
months) and a mean weight of 31 kg (range: 28-36.5 kg). During the study, the animals 
were fed daily with a standard laboratory diet (Altromin 9023, Altromin International 
Gmbh, Lage, Germany) and water ad libitum. 
 
ETHICAL CONSIDERATION 
For study III and IV, a license to perform the study was obtained from the Danish 
Experimental Animal Inspectorate, The Danish Veterinary and Food Administration, 
Ministry of Environment and Food of Denmark, Copenhagen, Denmark (Approval 
no. 2016-15-0201-00822). The studies design followed the ARRIVE guidelines for 
animal studies, and the experiment was performed per directive 2010/63/EU. 
 
SURGICAL PROCEDURE 
Paper II 
AB particles were harvested from the mandible of a pig with a bone scraper. The 
harvested bone was mixed with DBBM particles (Bio-Oss, Geistlich, Wolhusen, 
Switzerland), small particles (particle size 0.25-1 mm), and plasma from humans in 
the different ratios defined by weight. The different ratios of DBBM and PAB are 
illustrated in Figure 2. 
 
Figure 2. The different graft compositions used in study II 
 
The different ratios of DBBM and PAB were packed and condensed with a dental 
instrument in a roll of rice paper. All specimens were packed on weight in a 
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standardized way using a calibrated laboratory scale (50 g) to achieve the same 
pressure in all specimens. The specimens were fixed in formalin immediately after the 
packing procedure. 
 
Paper III and IV 
Harvesting of a mandibular bone block 
Through a submandibular skin incision, the lateral and inferior border of the mandible 
was exposed. With a fissure bur, a cortical bone block involving the lateral and inferior 
cortex (20 x 10 mm) was harvested. To finish the osteotomy, a chisel was used. The 
periosteum and skin were readapted and sutured in layers with Vicryl 3-0 and Nylon 
3-0 (Ethicon, Norderstedt, Germany). Finally, the wound was covered by tissue glue 
(Leukosan Adhesive, BSN medical GmbH, Germany). 
 
Lateral GBR augmentation of the mandible 
Preparation 
Through a submandibular skin incision in the contralateral side of the mandible from 
where the bone block was harvested, the lateral and inferior border of the mandible 
was exposed. On the lateral surface of the mandible, perforations were made with a 
small round bur (Ø1.2 mm, Stryker Corporation, USA) through the lateral cortex on 
four locations to mark the four recipient sites. The first recipient site was located 15 
mm from the posterior border of the mandibular ramus with an inter-recipient site 
distance of 10 mm. At the inferior border of the mandible, osteosynthesis screws (Ø2.0 
mm x 9 mm, Stryker Corporation, USA) were placed, corresponding to the midline of 
each augmented area, as a reference landmark for the orientation at the later 
histological preparation. AB from the mandibular ramus was milled in a bone mill 
(Roswitha Quétin Dentalprodukte, Germany) and mixed with DBBM (Bio-Oss, 
Geistlich, Wolhusen, Switzerland), small particles (particle size 0.25-1 mm) and 
blood from an ear vein of the study animals in the different ratios, defined by weight. 
The ratios of DBBM and bone are shown in Figure 3. 
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Figure 3. The different graft compositions used in study III 
 
Bone block 
The piece of the harvested bone block to use for LRA (10 x 10 x 4 mm) was prepared 
and applied passively to the lateral surface of the mandible and fixed with a titanium 
screw (Ø2.0 x 9 mm, Stryker Corporation, USA). With a round bur, rough corners 
were smoothened, and the bone block was covered with a 1 mm layer of 50% DBBM 
and 50% PAB, estimated by weight and a fixed resorbable collagen membrane (Bio-
Gide, Geistlich, Wolhusen, Switzerland). 
 
Different ratios of DBBM and PAB 
A specially fabricated stainless-steel frame (10 x 10 x 5 mm) was used to ensure a 
standardized quantity of the graft material at each recipient site. The grafting material 
was packed layer by layer with firm pressure until the stainless-steel frame was filled 
(Figure 4a). 
 
Figure 4a. Frame used to ensure a standardized quantity of graft material 
Figure 4b. The grafted region covered by a collagen membrane and fixed with pins 
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After removal of the frame, all augmented areas were covered with a resorbable 
collagen membrane (Bio-Gide, Geistlich Pharma, Wolhusen, Switzerland) and fixed 
with four titanium pins (Dentsply Frios, Astra Tech, Molndal, Sweden) (Figure 4b). 
The periosteum and skin were readapted and sutured in layers with Vicryl 3-0 and 
Nylon 3-0 (Ethicon, Norderstedt, Germany). Finally, the wound was covered by tissue 
glue (Leukosan Adhesive, BSN medical GmbH, Germany). 
The positioning of all four augmented areas is illustrated in Figure 5. 
Figure 5.  Illustration of the grafted regions 
 
 
Drug administration 
Anesthesia 
Anesthesia was induced by intramuscular injection in the neck region with a mixture 
of zoleteil (0.125 ml/kg, Rompun, Bayer Health care AG, Leverkusen, Germany), 
ketamine (1.6 mg/kg, Ketaminol, Intervet International B.V, Boxmeer, the 
Netherlands), and butorphanol (0.3 mg/kg, Torbugesic, Fort Dodge Veterinaria S.A., 
Girona, Spain). For anesthesia, a standard straight 5.5 mm orotracheal tube with a cuff 
(Portex, Kent, UK) was placed and anesthesia was maintained by inhalation 
anesthesia with 1% sevoflurane (Forene, Abott Gmbh, Wiesbaden, Germany). The 
animals received a continuous intravenous infusion through an ear vein of a 
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physiological saline solution containing propofol 10 mg/ml (4 mg/kg) and Fentanyl 
50 microgram/ml (0.03 microgram/kg) during the surgical procedure. 
 
Antibiotics 
Intramuscular injection with Curamox® Prolongatum Vet, Amoxicillinum 
Trihydricum, 150 mg/ml (0.1 ml/kg, Meda AS, Allerød, Denmark) was given one 
hour before surgery. Peroral Imacillin 50 mg/ml (14 ml/kg, Meda AS, Allerød, 
Denmark) was given twice a day on the third and fourth day postoperatively. 
 
Pain control 
An intramuscular injection with Metacam®, 5 mg/ml (2 ml/25 kg, Boehringer 
Ingelheim 3 A/S) was given preoperatively. Metacam®, oral suspension for pigs, 15 
mg/ml, (2.7 ml/100 kg, Boehringer Ingelheim Denmark A/S) was given peroral for 
five days postoperatively. 
 
Euthanasia and perfusion 
The animals were euthanized after 10 weeks, 20 weeks, and 30 weeks, respectively. 
Eight animals were euthanized at each time point. The animals were deeply 
anesthetized. The left and right common carotid arteries were exposed and dissected 
through a midline incision of the neck from the thyroid cartilage to just above the 
suprasternal notch. The carotid arteries were cannulated with a catheter (Avanti, 
Cordia Cashel, Ireland) and perfused with 1000 ml neutral-buffered Ringer solution 
(2500 ml/min) followed by 1000 ml neutral-buffered formaldehyde solution (2500 
ml/min). 
 
HISTOLOGY AND HISTOMORPHOMETRY 
Paper II 
The specimens were dehydrated in a graded series of ethanol before plastic embedding 
(LR White, London Resin Company Ltd, Berkshire, UK). The embedded specimens 
were then cut longitudinally (EXAKT cutting and grinding equipment; EXAKT® 
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Apparatebau GmbH & Co, Norderstedt, Germany). Each specimen was divided into 
the central portion, and processed into two ground sections measuring 12 x 12 mm 
and of 10-20 μm in thickness. Each specimen was stained with 1% toluidine blue. 
Descriptive histology and histomorphometric analysis were performed blindly on 
coded sections using a light microscope (Nikon Eclipse E600) connected to a 
computer with analytical software (Nikon Eclipse E600; Nikon NIS-Elements 
software). Histomorphometric analyses were performed using a 10x objective. In each 
section, three ROI of 2 x 2 mm were randomly assigned in each mixture by a person 
blinded to the different test groups (Figure 6). 
 
Figure 6. Illustration of the three ROIs chosen for histological assessment 
 
The histomorphometric analysis could be completed in 25 of 26 specimens (nine with 
the 50:50 ratio, eight with the 80:20 ratio, and eight with the 100:0 ratio) and 74 of 78 
ROI (26 with the 50:50 ratio, 24 with the 80:20 ratio, and 24 with the 100:0 ratio). 
The following histomorphometric measurements were performed in each ROI: 
1. Percentage of DBBM  
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2. Percentage of bone  
3. Percentage of NMT  
Data were presented as mean percentage values per section, where the area percentage 
of DBBM, bone, and NMT were calculated compared with the total area. 
 
Paper III 
Each specimen was immersed in 10% buffered formalin until the histological 
preparation was initiated. The specimens were rinsed in water followed by stepwise 
dehydration in a graded ethanol series, followed by embedding in plastic resin (LR 
White, London Resin Co. Ltd, UK). The embedded blocks were bisected 
corresponding to the reference screw inserted as a landmark inferior to each 
augmented area. Both bisected blocks of each specimen were used to prepare a 50 m 
thick central ground section (EXAKT1 Apparatebau GmbH & Co, Norderstedt, 
Germany) (126) stained with toluidine blue. All sections were coded and evaluated 
blindly. 
Qualitative and quantitative histology and histomorphometry were performed 
using light optical microscopy (Nikon Eclipse E600), following a calibration 
regarding different tissue types among the authors. All measurements were performed 
manually, directly on the computer screen connected to a microscope in Nikon NIS 
elements software. Four times magnification was used. In each specimen, a ROI was 
randomly selected. Following histological and histomorphometric measurements 
were made in all specimens: 
 
1. Percentage of bone, NMT, and DBBM 
2. Width of the augmented area (mm) 
3. Ingrowth of mineralized bone into the augmented area (percentage of the 
total width) 
 
To assess the ingrowth of mineralized bone, a straight line was drawn from the host 
bone to the lateral border in the central part of the transplant. Two supplementary 
straight lines were drawn parallel to the first line but 1 mm anterior and posterior for 
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it. A mean value (mm) for the three lines was calculated and acted as the value of the 
total width of the transplant. 
Three new lines from the host bone to the lateral border of the mineralized part of 
the transplant were drawn: one in the central part of the transplant and two parallel 
lines 1 mm anterior and 1 mm posterior for the first line. A mean value (mm) was 
calculated and acted as the value of the width of the mineralized bone. The width of 
the mineralized bone was divided with the total width of the transplant and resulted 
in a value corresponding to the percentage of ingrowth of mineralized bone into the 
graft (Figure 7). 
 
 
Figure 7. Illustration of the method used to measure the ingrowth of mineralized bone 
into the graft 
 
RADIOLOGY 
Paper IV 
CT volumes (Discovery CT750 HD, General Electric Company, United States) were 
acquired with 0.625 mm section thickness and 0.312 mm distance between the 
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sections. The animals were placed in a supine position with a horizontal occlusal 
plane. Two sets of CT volumes were acquired (i.e. immediately after the surgery and 
after euthanasia). To provide blinding of the radiographic evaluation, the CT volumes 
were coded. 
 
Width changes    
The dimensional (linear) changes of the augmented regions were measured by two-
dimensional linear measurements on axial CT images acquired postoperatively and at 
euthanasia in Romexis software (version 5.3, Planmeca Oy, Finland). A straight line 
was demarcated through each augmented region corresponding to the middle of the 
reference screw at the inferior mandibular border. Two parallel lines were drawn 
anteriorly and posteriorly at two millimeters from the first line, respectively (Figure 
8). The vertical distance from the positioning screw to the center of the transplant was 
measured to find the correct position for the measurements in the corresponding 
volume at euthanasia. The initial width of the mandible was measured in millimeters 
from the outer lingual cortical surface to the outer facial cortical surface of the 
mandible at three points, corresponding to the three parallel lines. The width of the 
mandible, including the augmented region, was measured in millimeters from the 
outer lingual cortical surface of the mandible to the most lateral part of the augmented 
region at three points, corresponding to the three parallel lines. The width of each 
augmented region was estimated by subtracting the initial width of the mandible from 
the width of the mandible, including the augmented region. A mean value was 
calculated for each of the augmented regions corresponding to the three lines on axial 
CT images obtained immediately postoperatively and after euthanasia. However, the 
border between the augmented region and the outer facial cortical surface of the 
mandible was difficult to distinguish on certain CT images at euthanasia. Therefore, 
the initial width of the mandible, which was measured on postoperative CT images, 
was subtracted from the width of the mandible, including the augmented region on 
CT images at euthanasia.  
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Figure 8. Illustration of the method used to measure the width of the grafted regions 
 
Volumetric changes 
To evaluate the volumetric changes of the augmented regions, three-dimensional 
measurements on coronal CT-scan images were acquired postoperatively and at 
euthanasia. The two sets of CT scans were uniformly oriented according to the lines 
using the On Demand software (CyberMed, Seoul, South Korea). Initially, a straight 
line between the centers of the two most posterior membrane fixation pins was defined 
based on the sagittal plane (Figure 9a). Perpendicular to the posterior line, a straight 
line in the lateral-medial direction corresponding to the middle of the inferior fixation 
pin was demarcated (Figure 9b). The posterior line, which was located posteriorly for 
the first augmented region, served as a starting point for the selection of CT-scan 
images when transferred to the coronal plane. The section thickness was set to 1 mm 
and coronal CT images, from the starting point until the anterior membrane fixation 
pins of the fourth augmented region were selected, and exported as separated TIF 
images, thereby ensuring an equal mutual distance between the selected images. Each 
image included a ruler, which allowed the setting of a linear scale (127, 128). The area 
of interest of the TIF image was outlined using a software program (ImageJ; National 
Institutes of Health, Bethesda, MD, USA) by manually tracing the structure with a 
computer mouse (Figure 10a, 10b) The area of each selected section was multiplied 
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by 2, providing the volume for that section, due to the 2 mm distance between sections, 
before the total volume for each of the augmented region was estimated by adding the 
counted volume value of each selected sections (i.e. Cavalieri’s principle). The 
volumetric changes of the augmented regions in mm3 were finally calculated by 
subtraction of the estimated volume of the augmented region on CT obtained at 
euthanasia from the estimated volume on postoperative CT volume. 
 
Figure 9ab. Illustration of the landmarks used for orientation of the CT volumes 
 
 44 
Figure 10a. The augmented region outlined on the CT volume postoperatively 
Figure 10b. The augmented region outlined on the CT volume at euthanasia 
 
STATISTICS 
Paper II 
Results were reported as mean values and 95% CI. Differences in the amount of 
DBBM, bone, and NMT were tested using mixed models with the mixture as a fixed 
factor and ROI as a random factor. Model assumptions, that is, normally distributed 
random effects with constant variance, equal across compositions, were verified by 
visual inspection of graphs of residuals and predicted values. A statistically significant 
difference was considered at p<0.05. All statistics were performed using STATA 
version 14 (Stata Corp P, TX, USA). 
 
Paper III 
Data management and statistical analyses, including the calculation of descriptive 
statistics, were conducted using the statistical software STATA version 16.1 (Stata 
Corp P, TX, USA). The outcome was the percentage of bone, NMT, and DBBM. Data 
were analyzed in a mixed model for normally distributed data with the percentage of 
bone, NMT, and DBBM as the dependent variables. Graft composition, time points, 
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the interaction between time point and graft composition, and position are fixed 
factors, while the animal is a random factor. The specified correlation structure 
allowed the error variance to be different at different time points. The mixed models 
were fitted using the function lme from the R package nmle. Pairwise testing of 
differences in the percentage of bone, NMT, and DBBM between time points within 
graft compositions and between graft compositions within time points was performed 
based on marginal means of the mixed models. P-values and CIs were adjusted for 
multiple testing within time points and graft compositions using Tukey’s method. 
Results were summarized as mean values with a 95% CI. A statistically significant 
difference was considered at p<0.05. 
 
Paper IV 
For a convenient number of animals in Study III and IV, a power calculation based on 
the outcome in Study IV was conducted to define an adequate number of animals. A 
post hoc sample size calculation based on an alpha significance level of 0.05 to 
achieve 80% power to detect a clinically meaningful difference of 8% (SD: 5.0) in 
volume reduction between two of the groups at one healing period, suggested that 8 
animal in each group were enough to detect a difference of 8% why we regarded 24 
animals to be an adequate number for the study. Data management and statistical 
analyses including the calculation of descriptive statistics were conducted using the 
statistical software R version 2.8.0. (R Foundation for Statistical Computing, Vienna, 
Austria). Data were analyzed in a mixed model for normally distributed data with the 
percentage of volumetric and dimensional changes of the graft material as dependent 
variables. The composition and position of the graft material on the lateral surface of 
the mandible were selected as fixed factors, while the animal was used as a random 
factor. The mixed models were fitted. Pairwise testing of differences in volumetric 
and dimensional changes of the graft material between each ratio was conducted. 
Results were summarized as mean values with 95% CI and SD. A statistically 
significant difference was considered at p<0.05. 
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RESULTS 
The main results of studies (I-IV) are presented below. 
 
Paper I 
High short-term implant survival was demonstrated for LRA with DBBM in 
combination with PAB.  Lateral GBR augmentation with DBBM alone or in 
combination with PAB seemed to induce bone formation. No studies evaluating 
DBBM alone presented results considering the survival of suprastructure, implant 
survival, gain in the width of the alveolar process, or volumetric stability. 
 
Paper II 
The mean area fraction in percent of DBBM, bone, and NMT is presented in Table 1. 
Table 1. Mean area fraction in percent of DBBM, bone, and NMT in study II 
 
Based on the results from the histomorphometric analyses, a prediction curve was 
calculated, which illustrates the relation between the values of the clinically estimated 
percentage of DBBM and the predicted histomorphometrical area fraction of DBBM 
(Figure 11). By the means of the curve, estimated histomorphometrical area fraction 
at baseline of any composition of DBBM and PAB can easily be predicted using the 
following formula: mean [RealDBBM] = β x [ExpectedDBBM] where β is a 
coefficient of 0.42, calculated from the observations in this study, and estimating the 
mean value of the real area fraction of DBBM to be 42% of the expected area fraction. 
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Figure 11. Prediction curve illustrating the relation between the values of the 
clinically estimated percentage of DBBM and the predicted histomorphometrical area 
fraction of DBBM 
 
Paper III 
The different compositions of DBBM and PAB and ABB displayed various stages of 
integration with the host bone after 10 weeks, 20 weeks, and 30 weeks of graft healing. 
Specimens containing different compositions of DBBM and PAB showed DBBM 
particles embedded in mineralized bone and NMT at all time points. DBBM particles 
adjacent to the host bone were generally more integrated into mineralized bone 
compared to particles located adjacent to the periosteum. ABB demonstrated a zone 
of NMT between the graft and host bone after 10 and 20 weeks, whereas an almost 
complete integration was observed after 30 weeks. Signs of remodeling and formation 
of primary osteons were observed after 20 weeks of healing. 
The mean POB for the different compositions used during GBR were 54% (50:50), 
50% (75:25), and 48% (100:0) after 10 weeks; 60% (50:50), 61% (75:25), and 60% 
(100:0) after 20 weeks; and 63% (50:50), 62% (75:25), and 62% (100:0) after 30 
weeks. The POB were similar for all compositions at all time points, and no 
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statistically significant differences could be detected (p>0.05). However, there was a 
significant increase in POB from 10 weeks to 30 weeks for 75:25 (p=0.02) and 100:0 
(p=0.01). 
The mean percentage of NMT for the different compositions were 25% (50:50), 
27% (75:25), and 26% (100:0) after 10 weeks; 18% (50:50), 15% (75:25), and 15% 
(100:0) after 20 weeks; and 22% (50:50), 16% (75:25), and 16% (100:0) after 30 
weeks. The amount of NMT was similar for all compositions at all time points, and 
no statistically significant differences could be detected (p>0.05). However, there was 
a significant decrease in percentage of NMT from 10 weeks to 30 weeks for 75:25 
(p=0.05) and 100:0 (p=0.04). 
The mean percentage of DBBM for the different compositions were 21% (50:50), 
23% (75:25), and 26% (100:0) after 10 weeks; 22% (50:50), 24% (75:25), and 25% 
(100:0) after 20 weeks; and 16% (50:50), 22% (75:25), and 22% (100:0) after 30 
weeks. 
Histomorphometric results after 10, 20 and 30 weeks are presented in Figures 12, 
13, and 14. 
Figure 12. The mean percentage of bone, NMT, and DBBM after 10 weeks 
 
 50 
Figure 13. The mean percentage of bone, NMT, and DBBM after 20 weeks 
 
Figure 14. The mean percentage of bone, NMT, and DBBM after 30 weeks 
 
No significant difference regarding the percentage of different tissues was observed 
between any of the compositions of DBBM and PAB at any time point. There was a 
significant increase in POB and a significant decrease in NMT for 75:25 and 100:0 
from 10 to 30 weeks. All compositions demonstrated a non-complete ingrowth of 
mineralized bone into the graft after 10 weeks and complete mineralization after 30 
weeks (Figure 15). 
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Figure 15. Ingrowth of mineralized bone into the graft material over time 
 
Paper IV 
Width changes 
The gained width was 3.1 mm (±2.6) for 50:50, 3.0 mm (±2.3) for 75:25, 2.9 mm 
(±1.0) for 100:0, and 4.6 mm (±1.4) for ABB after 30 weeks. The width reduction was 
-1.7 mm (-33.1%) for 50:50, -1.8 mm (-37.8%) for 75:25, -1.7 mm (-35.8%) for 100:0, 
and -0.2 mm (-3.7%) for ABB after 30 weeks. The width changes over time are 
illustrated in Table 2 and Figure 16. 
The ABB presented significantly less reduction compared to 50:50, 75:25, and 100:0 
after 10 weeks (p=0.00), after 20 weeks (p<0.01), and after 30 weeks (p<0.05). There 
was no significant difference among the particulate grafts. 
 
Table 2. The mean width reduction and gained width for all graft compositions over 
time where * represents a statistically significant difference (p<0.05). 
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Figure 16. Illustration of width changes in mm over time 
 
Volumetric changes 
The number of images for each augmented area varied between five and nine, 
depending on the displacement of graft material, but the same number of sections was 
generated and evaluated for each augmented area in both sets of CT images. The mean 
volume and SD, as well as the volume reduction in percent for all graft materials, are 
presented in Table 3. 
A comparison of the volumetric reduction between the different compositions at 
each time point is presented in Table 4. There was no statistically significant 
difference between any of the compositions at 30 weeks, but 100:0 presented a 
reduced reduction compared to all other grafts at 10 and 20 weeks. The volumetric 
changes over time are illustrated in Figure 17. 
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Table 3. The mean volume for all compositions overtime where * represents a 
statistically significant difference (p<0.05). 
 
Table 4. Comparison of the volumetric changes for the different graft compositions 
over time where * represents a statistically significant difference (p<0.05). 
 
Figure 17. Illustration of volumetric changes over time 
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DISCUSSION 
The purpose of this thesis was to assess the regenerative outcome after lateral GBR 
augmentation using different compositions of DBBM and PAB and ABB covered 
with DBBM and a resorbable collagen membrane at different time points. 
 
Comments on material and method 
Paper I 
The present study was conducted to evaluate conclusions from previous studies 
assessing LRA with DBBM alone or in combination with PAB. The number of 
included studies was small, and only five studies met the inclusion criteria. A meta-
analysis was not possible due to considerable variations in design. However, well-
designed studies on LRA with DBBM alone or in combination with PAB were sparse. 
 
Paper II 
Three different compositions were chosen (50:50, 80:20, and 100:0) due to its 
common use in the clinical situation. It could have been an advantage to choose 75:25 
instead of 80:20 due to the use of 75:25 in Study III and IV. However, 5% will 
probably not have an impact on the results, and it would possibly be in the range of 
normal variation when the compositions are mixed by weight. 
 
Paper III and IV 
DBBM is frequently mixed with PAB in different compositions, varying from 0% to 
50% to add osteoinductive properties (24, 27, 31-33, 36, 37, 77, 129). Thus, the 
optimal composition of DBBM and PAB is presently unknown. In the present study, 
three different compositions of DBBM and PAB was used: 50:50 since it in larger 
reconstructions probably demands a donor site to achieve a sufficient amount of bone, 
75:25 since the 25% of bone in most cases can be collected with a bone scraper in the 
surgical site, and 100:0 since it would be a great advantage if no PAB is required. 
Previous experimental studies assessing different compositions of DBBM and 
PAB have mainly assessed bone formation in the early healing phase (8-12 weeks) to 
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provide information regarding biocompatibility of the material, early cellular 
response, and persistence and condition of the transplant within the defect. In clinical 
settings, implants are usually placed seven to ten months after LRA (24, 31-33, 77), 
and histomorphometrical and histological assessment after a prolonged healing period 
and at different time points could provide valuable knowledge on bone regeneration 
and incorporation of the graft material before implant placement. The present study 
included one healing period to evaluate the early response (ten weeks) and two healing 
periods that correspond to clinical settings where mineralization and incorporation of 
the graft material, the quantity of the material, and placement of the evaluated material 
is comparable to the clinical situation for LRA. 
 
Bone formation 
Since the histomorphometric analyses did not differ between newly formed bone and 
bone from the graft, the analyses of the ABB were not as relevant as for the particulate 
grafts since it consists only of bone at the moment of grafting. However, the ABB 
presented with a line of non-mineralized tissue between the graft and the host bone 
during the first 20 weeks of healing, and complete fusion of the graft with the host 
bone was first detectable after 30 weeks of healing. Hence, a prolonged healing period 
had a positive impact on the incorporation of ABB. 
The histomorphometric results of Study III revealed no significant difference 
regarding the percentage of bone between any of the compositions of DBBM and PAB 
at any time point. However, the percentage of bone increased significantly between 
10 and 30 weeks at the expense of non-mineralized tissue. When investigating the 
pattern of ingrowth of mineralized bone into particulate grafts, mineralization was 
gradually seen from 10 to 30 weeks with complete mineralization after 30 weeks, 
which corresponds to a previous statement that bone is formed with an approximate 
rate of 1 mm per month (130). Hence, the addition of PAB to DBBM did not seem to 
influence the regenerative outcome, but the consolidation period seems to have an 
impact on the mineralization of the graft, even for the ABB. 
It has previously been stated that DBBM only achieves bone formation by 
osteoconduction due to the lack of proteins in the material. Hence, the addition of 
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PAB with its osteoinductive properties is necessary for sufficient bone formation (96). 
In contrast, it has been suggested that a small amount of proteins is present in DBBM 
and that the material probably possesses osteoinductive properties in a limited degree 
(131). This could explain why the results from Study III and clinical studies evaluating 
LRA histologically with 100% DBBM presented bone formation, comparable to 
grafts with the addition of PAB (25, 132). 
The well-known osteoconductive properties of DBBM make it act like a scaffold 
to permit the formation of new bone determined by the biology of the graft and the 
mechanical environment of the host-graft interference (107). It has also been proposed 
that the process of bone formation depends on the number and size of channels 
through the grafts to permit the ingrowth of osteoprogenitor cells, capillaries, and 
perivascular tissue (133). 
Study II demonstrated that in a graft consisting of 100% DBBM, the DBBM 
particles only occupy 43.5% of the total area at the moment of grafting and the 
remaining 56.6% is non-mineralized tissue (i.e. blood and space between DBBM 
particles) even after a firm compression of the graft. Hence, in a graft with 100% 
DBBM, there is probably space enough for bone ingrowth between the DBBM 
particles if soft tissue ingrowth is occluded by a membrane due to the principles of 
guided bone regeneration. The results from Study II also concluded that information 
about the area fraction of a biomaterial at only one specific time point cannot be used 
to estimate material resorption. As mentioned, a graft material consisting of 100% 
DBBM consists solely of 43.5% DBBM, and a biopsy assessing the area fraction of 
DBBM after a healing period is only useful if it is compared to a baseline. 
The percentage of DBBM in study III maintained without any significant changes 
during the entire observation period. Hence, the presented percentage of DBBM of 
21% in the 100:0 mixture in study III is not a result of the resorption of DBBM 
particles. These findings have previously been presented (95). 
 
Dimensional stability 
The GBR technique is a well-documented method to enhance bone volume (11, 134, 
135). The technique has been applied for lateral augmentation with DBBM in 
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combination with a resorbable membrane (31-33, 36, 37) as well as with ABB in 
combination with DBBM and a resorbable membrane (14-16, 18). 
ABB remains the gold standard for many clinicians, but the technique has some 
disadvantages. The increased morbidity caused by bone harvesting, the high 
resorption rate of the graft, and the lack of long-term studies not only assess implant 
survival but also the stability of the augmented bone volume over time (15). 
To cover the ABB with a non-resorbable ePTFE membrane according to the GBR 
technique, have previously been documented to minimize the resorption of the ABB 
with satisfactory results (14). To simplify the technique, resorbable collagen 
membranes have been utilized. Due to the short duration of barrier function, a non-
resorbable bone substitute has been applied on the surface of the ABB to protect the 
bone block from surface resorption (16, 18). 
The use of ABB without coverage of DBBM or in combination with GBR has 
reported an extensive resorption rate as high as 78% after two years (71) and 87% 
after six years (136). To cover the ABB only with DBBM has reduced the resorption 
rate to 9.2% (17) and to apply the GBR technique with a resorbable membrane has 
been reported to further decrease the resorption rate to 6.9% after six months and 7.7% 
after ten years (15). When applying the GBR technique on ABB covered by DBBM, 
a gained width of the ridge presented was 7.75 ± 0.99 mm and the width reduction 
was 0.38 mm after ten years, and the resorption from six months to ten years was not 
significant (15). In study IV, the ABB in combination with DBBM and a resorbable 
collagen membrane presented a gained width of 4.2 ± 1.4 mm after 30 weeks.  It is 
challenging to compare the gained width among studies, since it depends on the 
amount of correction of the defect. 
In Study IV, the bone block was adjusted to 4 mm in width and the covering layer 
of DBBM was 1 mm to make a comparable starting point with the particulate graft, 
which was 5 mm in width. However, the resorption of the ABB in study IV was 0.2 
mm, which is a more reliable number since it does not depend on the intra- or post-
operative width. Hence, it seems possible that the resorption rate for ABB covered by 
DBBM and a resorbable collagen membrane is less than 0.5 mm, even if the 
augmented region is exposed to extensive pressure postoperatively, as in study IV. 
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Even if the resorption rate is minimized by covering the bone block with DBBM and 
a membrane, the risk of donor site morbidity remains. A previous RCT that applied 
GBR with ABB and DBBM showed an increased rate of sensory disturbances after 
augmentation with ABB compared to particulate grafts (32). 
Systematic reviews have presented a superior gain for ABB compared to 
particulate grafts, but it does not seem to have an impact on the implant survival rate 
of the implants (12, 44). Regarding particulate grafts, there is wide variation in the 
gained width when different compositions of DBBM and PAB have been evaluated 
radiologically after lateral GBR augmentation with two-dimensional measurements. 
In general, the stability of the graft during the consolidation period by fixation of the 
membrane seems to be an important factor for the increased width. Clinical studies 
have demonstrated a superior increase in the width of the alveolar process when the 
graft material was stabilized under a membrane fixed with titanium pins. Fixation of 
the membrane presented a gained width of 5 mm after seven months (31) and 5.6 mm 
after seven to nine months (32), while no fixation presented a gained width of 3.6 mm 
(77) and 3.5 (34) after nine months. The particulate grafts in study IV presented a 
gained width between 3.1 mm and 3.4 mm after 30 weeks, which is a reduced width 
compared to previous studies. This could, like in the ABB situation, be explained by 
less correction of the defects compared to previous studies. It could also be explained 
by extensive pressure on the augmented regions due to the postoperative behavior of 
the study animals. 
Another challenge in comparing the results between different study designs could 
be the method applied for the measurements. It has been demonstrated that the coronal 
aspect of the graft maintains the width to a lesser degree compared to the apical part 
(24, 137). Hence, the vertical position of the measurements could affect the results. 
Within the same study, it can also be challenging to apply the measurements in the 
same position when assessing the width over time. 
A disadvantage with preclinical studies like study IV is the lack of clinical 
measurements, which probably would complement the radiographic measurements 
since clinical studies have described a softer surface in augmented sites with 
removable graft particles, which cannot be detected during radiographic assessment.   
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According to previous studies, assessing width changes after lateral GBR 
augmentation, it seems like a firm and stable graft probably will counteract 
compression of the augmented area and might be more important than the graft 
composition. 
It is not possible to evaluate the clinical impact of the difference in gained width 
in study IV since no implants have been placed. A systematic review concluded that 
implant survival was higher after placement in augmentation with bone substitutes in 
combination with PAB compared to implants placed in AB alone (138). To evaluate 
the benefits and disadvantages of ABB and particulate grafts, clinical studies with 
long-term follow-up must be conducted. 
 
Volumetric changes 
Two-dimensional radiographic measurements will show dimensional changes only in 
a selected area, which can be misleading. A three-dimensional volumetric assessment 
will show the full area in which the graft has been placed. In grafted areas, there is 
always a difference comparing the center of the area and the boundaries, which could 
be a bias in studies assessing graft materials (128). Two-dimensional measurements 
are often performed in the center of the graft material. However, in clinical settings 
after LRA, the center of the graft is probably where you will place your implant, and 
the boundaries may not be as important as the center of the graft. 
CBCT has been proposed to be a potentially efficient tool to evaluate the treatment 
outcome after grafting procedures or for long-term monitoring of the graft (139, 140) 
since the technique has a relatively low radiation dose and image acquisition time 
(141). CBCT images have previously been used to assess the fate of bone grafts (24, 
29, 31-33, 136, 142, 143). However, the settings for image sectioning and display, 
such as section thickness and mapping of scalar values stored within the image shown 
to the user (e.g. contrast control), can vary (144, 145), and these settings may have a 
large impact on the characteristics of the final images, as shown in a recent review 
(146). 
CBCT provides a three-dimensional illustration of the grafted area but still, the 
most common measurements performed in CBCT images following lateral GBR 
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augmentation are the two-dimensional measurement (15, 24, 31, 32). As well as for 
dimensional changes, the measurement protocol for volumetric changes varies among 
studies, and it can be challenging to compare the volumetric changes. 
The protocol for volumetric measurements in study IV has previously been applied 
for evaluating volumetric changes after lateral augmentation (147). The idea of the 
applied protocol was to generate the same sections on the CT scan at different time 
points for assessment. The number of sections varied among the animals depending 
on individual width and the placement of the grafted regions, but the same number of 
sections was generated and evaluated for each particular augmented area in the scan 
acquired postoperatively and the scan acquired at euthanasia (127, 128, 147). This 
standardization is not always present in the studies available in the literature. 
In study IV, the graft with 100% DBBM presented significantly less volume 
reduction compared to all other grafts after 10 and 20 weeks. However, after 30 weeks, 
there were no differences in the volumetric changes between the ABB and the 
particulate grafts, nor among the particulate grafts. 
The results from the volumetric measurements in study IV should be regarded with 
caution since some grafted areas presented an increased volume over time instead of 
a volume reduction. The increased growth in bone mass was mainly seen superiorly 
and inferiorly and anteriorly and posteriorly for the grafted areas and was primarily 
seen after 30 weeks of healing and not at the earlier healing periods. The increased 
bone volume could be explained because of osteoconduction due to the space created 
by the tenting of the periosteum, which has previously been described (148). The 
increased growth of bone was rarely seen lateral of the augmented area, why the two-
dimensional measurements might be more reliable in study IV. 
The fact that a graft comprising DBBM presents less volume reduction has 
previously been presented. A preclinical study in rabbit calvaria assessing the volume 
stability of grafts with different compositions of DBBM and PAB in metallic cylinders 
presented less volume resorption in grafts with 100% DBBM or composition of 
DBBM and PAB compared to PAB alone (149). 
A preclinical study in minipigs assessing different compositions of DBBM and 
PAB in conjunction with maxillary sinus floor augmentation demonstrated that the 
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volumetric changes of the graft material were significantly influenced by the 
composition of DBBM and PAB with minimal resorption of the graft material when 
DBBM was used alone (29). However, the biological environment and demands on 
mechanical stability after augmentation in stable metallic cylinders or in the maxillary 
sinus differ from the demands after lateral augmentation, since the metallic cylinder 
and the maxillary sinus are closed compartments where no pressure will be applied 
after the augmentation procedure. The lateral procedure will result in pressure on the 
augmented from the overlying mucosa, cheeks, and lips. 
The volume reduction at 20 weeks was 18-37% for different compositions of 
DBBM and PAB, including the ABB covered by DBBM in study IV. The graft 
consisting of 100% DBBM maintained a significantly better volume compared to all 
other grafts. Since DBBM is a non-resorbable bone substitute, this could explain 
superior volumetric stability, especially since the grafts presenting the highest 
reduction were the graft with the highest amount of autogenous bone (i.e. the bone 
block and the 50:50 composition). PAB has previously shown extensive resorption 
when used for lateral augmentation (71). 
Studies presenting volumetric changes assessed by three-dimensional 
measurements after lateral ridge augmentation are sparse. Three-dimensional 
measurements on cone-beam CT volumes for two different compositions of DBBM 
and PAB (90:10 and 60:40) revealed a volume reduction of 55.3% and 53.8%, 
respectively, after eight months. There was no significant difference in volume 
reduction between the two compositions (34). A retrospective study evaluating the 
volume reduction of an ABB from the iliac crest compared to a particulate graft 
demonstrated a reduced volume reduction for the particulate graft compared to the 
ABB (150). Consequently, the conclusions on the volumetric outcome after lateral 
GBR augmentation with DBBM and PAB, as well as for ABB covered by DBBM, 
are still inconsistent and must be systematically evaluated in clinical studies. 
The radiographic protocol for the volumetric measurements in study IV seems 
feasible but is time-consuming. Hence, it can be discussed how beneficial the three-
dimensional measurements are in the lateral situation since only one dimension of the 
alveolar process has to be augmented and it might be enough to acquire information 
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about that particular dimension (i.e. two-dimensional measurements).  As opposed to 
defects where two dimensions must be augmented to achieve sufficient bone volume 
(i.e. combination of vertical and lateral augmentation or maxillary sinus floor 
augmentation). The cost-benefit effect could be interesting to include in future studies. 
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CONCLUSION 
 
1. The histomorphometrically evaluated percentage of DBBM at baseline 
before grafting is inferior compared to the estimated percentage of DBBM 
in the graft.  
 
2. The addition of PAB to DBBM does not seem to enhance the bone formation 
of the graft. 
 
3. A prolonged consolidation period has a positive influence on the ingrowth of 
mineralized bone into the graft, independent of the composition of DBBM 
and PAB. 
 
4. The width of the graft material seems to be better maintained with ABB 
covered with a non-resorbable bone substitute compared to particulate grafts 
with DBBM alone or in combination with PAB. The addition of PAB to 
DBBM does not seem to influence the width in particulate grafts. 
 
5. The volumetric changes of the graft material seem to be comparable for ABB 
covered with a non-resorbable bone substitute and for particulate grafts with 
different compositions of DBBM and PAB after a prolonged healing period.  
In the early healing phase, DBBM alone seemed to maintain the width better.  
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CLINICAL IMPLICATIONS AND FUTURE PERSPECTIVES 
It has been suggested that priority should be given to those bone augmentation 
procedures that simplify the surgical procedure, are less invasive, present the less risk 
of complications, and reach their goal within the shortest time frame (10). To 
completely or partly replace the harvesting of AB with bone substitutes will simplify 
the surgical procedure and be less invasive since there will be no need for bone 
harvesting from another surgical site; it would reduce the risk of sensory disturbances 
and shorten the treatment time frame. 
The results from this Ph.D. thesis should be regarded with caution since it is an 
experimental study that is not directly applicable to humans. However, the results 
demonstrated that ABB covered by DBBM maintains a better width of the grafted 
region compared to particulate grafts. Adding different compositions of PAB to 
DBBM could not reveal an enhanced bone formation, an increased gain in width, or 
a reduced volumetric reduction compared to DBBM alone. It can be discussed 
whether the superior gain in width for the ABB compared to particulate grafts has a 
clinical impact or not. This matter was not possible to assess in this Ph.D. thesis since 
no implants were installed. 
Within the limitations of this Ph.D. thesis, it seems like the addition of PAB to 
DBBM in particulate grafts is not necessary. However, lateral GBR augmentation 
with 100% DBBM should be investigated in well-designed clinical studies with 
systematic long-term follow up on implant survival and the stability of augmented 
bone volume over time with standardized radiographic protocols where the width of 
the residual bone and the dimension of the applied graft are considered. The cost-
benefit effect of different radiographic protocols should be evaluated.  
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